AIM
PGNX

Acrospire Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Acrospire Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,014
Closed -$28K – 2705
2017
Q1 		$28K Sell
3,014
-27,499
-90% -$255K 0.02% 1413
2016
Q4 		$264K Buy
30,513
+22,713
+291% +$197K 0.11% 198
2016
Q3 		$49K Buy
+7,800
New +$49K 0.03% 1090